跳至主要内容
临床试验/NCT03606811
NCT03606811已完成不适用

The Role of Double Modality " Fluoroscopic &Ultrasonographic " Guidance of Superior Hypogastric Plexus Neurolysis in Treating Intractable Pelvic Cancer Pain: a Comparative Study.

Assiut University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2018年8月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
pain relief will be assessed by VAS

研究概览

简要总结

fluoroscopic group & includes 30 patients where SHPB will be done Fluoroscopic-guided (the posterior oblique trajectory technique.the double modality group & includes 30 patients where SHPB will be done using our described new technique of performing the modified Mishra technique by injecting 3-5 ml of contrast media (lohexol=omnipaque) after getting the target position.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years.
  • Intractable pelvic cancer pain (VAS > 40 mm)
  • Pain is refractory to pharmacotherapy (both opioids and adjuvant therapy) or opioids' side effects are not tolerated.
  • Exclusion criteria
  • Local or systemic sepsis.
  • Uncorrectable coagulopathy.
  • Neuropsychiatric illness.
  • History of drug abuse.
  • Pregnant or lactating patients.
  • Distorted local anatomy.
  • Patients who are known to be allergic to the used medications.
  • Cardiovascular or respiratory instability.

排除标准

  • 未提供

结局指标

主要结局

pain relief will be assessed by VAS

时间窗: 12 weeks

pain relief will be assessed by VAS (visual Analogue score) which is 100 mscale with left (0) end means no pain \& right (10) end means the worst possible pain

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed H Othman

Assisstant professor of Anesthesia ICU and pain Relief

Assiut University

研究点 (1)

Loading locations...

相似试验